AzTrials
AzTrials

Trigger FingerNCT04675892

Resection of Flexor Digitorum Superficialis Tendon for Severe Trigger Fingers

A study testing A1 pulley division and A1 pulley division + Resection of one or both slips of the FDS tendon in people with Trigger Finger and Stenosing Tenosynovitis, run by Centre Hospitalier Universitaire Vaudois at 1 site in Switzerland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the effectiveness of resection of one or both slips of the flexor digitorum superficialis tendon versus the A1 pulley division. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Trigger Finger, Stenosing Tenosynovitis
What is being tested?
A1 pulley division and A1 pulley division + Resection of one or both slips of the FDS tendon
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteSwitzerland
Study dates
1 Nov 2018to 31 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients (≥18 years old) with a flexor tendon tenosynovitis of a finger resulting in a decreased range of motion of the PIP joint (defined with a palm-to-pulp distance ≥0mm and/or flexion contracture ≥15°).

Who cannot join

  • Minors (<18 years old).
  • PIP joint contracture resulting from another illness than stenosing flexor tenosynovitis (for example: rheumatoid arthritis) or caused by a traumatic event.
  • Contraindications to any surgery: presence of a severe coagulation disorder, immunosuppression or decompensated psychiatric illness.

Trial locations and contacts

1 site in 1 country.

Thierry Christen, MD contact

+41(0)795561287

thierry.christen@chuv.ch

Switzerland1 site, 1 recruiting
  • CHUV

    Lausanne, Canton of Vaud, 1011

    Thierry Christen, MD, +41(0)795561287, thierry.christen@chuv.ch

    Recruiting

Other trials in Switzerland

About this study

Official title: Resection of One or Both Slips of the Flexor Digitorum Superficialis Tendon for Cases of Severe Trigger Fingers. a Randomized Prospective Single Center Study

The purpose of this study is to compare the effectiveness of resection of one or both slips of the flexor digitorum superficialis tendon versus the A1 pulley division.

Read the detailed description

The preoperative visit occurred a number of weeks or months prior to surgery. Surgeons from the Centre de la main at the CHUV in Lausanne recruited the subjects during their consultations. During this initial visit, the patient was asked about his problem, his general health and a clinical examination (including range of motion of finger joints, pulp-to-palm distance, pain evaluated with a VAS) was performed. Once the diagnosis of trigger finger was established, the inclusion and exclusion criteria were evaluated. If the eligibility criteria were fulfilled, the patients were offered to be part of the study. They received oral and written information about the study and the surgeons gave further explanation if needed.

On the surgery day, the signed consent form was recovered. Participants were randomized in two groups according to a computer-generated list ranging from 01 to 60 (www.randomization.com). Surgery was then performed according to the method chosen by randomization. The possible occurrence of adverse effects during surgery was monitored. All information was recorded on the case report forms.

The first postoperative visit occurred 1 week ± 3 days after surgery. The surgeons evaluated the wound to exclude the presence of postoperative complication (infection, hematoma, nerve or tendon injury) and answer any question the patient could have. Range of motion and pain were recorded. All information was recorded on the case report forms.

The second postoperative visit occurred 4 weeks ± 5 days after surgery. The appointment was conducted in the same way as the previous one.

Patients could choose to be withdrawn from the study at any point. The follow-up was similar to that of patients included in the study.

Being tested
A1 pulley division, A1 pulley division + Resection of one or both slips of the FDS tendon
Keywords
trigger finger, stenosing flexor tenosynovitis
Medical subject headings
Trigger Finger Disorder, Tendon Entrapment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • A1 pulley divisionProcedure or surgery

    Local anesthesia with 5-10 ml of solution required (90 % lidocaine 1 % with 1 ug epinephrine, 10 % sodium bicarbonate 8.4 %).

    Division of the A1 pulley.

    Wound closure with absorbable sutures and application of a light dressing.

  • A1 pulley division + Resection of one or both slips of the FDS tendonProcedure or surgery

    Local anesthesia with 5-10 ml of solution required (90 % lidocaine 1 % with 1 ug epinephrine, 10 % sodium bicarbonate 8.4 %).

    Division of the A1 pulley.

    Palmar Bruner incision over the PIP joint. Distal dissection and resection of one or both slips of the FDS tendon.

    Wound closure with absorbable sutures and application of a light dressing.

Study groups in NCT04675892
Study groupRoleWhat they receive
A1 pulley groupActive comparatorA1 pulley division only
Receives: Procedure: A1 pulley division
A1 pulley + FDS groupExperimentalCombination of A1 pulley division and excision of one or both slips of the flexor digitorum superficialis tendon
Receives: Procedure: A1 pulley division + Resection of one or both slips of the FDS tendon

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in total active finger motion in degrees

    Change in preoperative and postoperative overall range of motion of the finger joints in degrees

    Measured: Preoperative (days to weeks prior to surgery), 4 weeks after surgery

Secondary outcomes (1)
  1. Change in with the visual analog scale

    Change in pain with the visual analog scale

    Measured: Preoperative (days to weeks prior to surgery), 4 weeks after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2020
  2. Study start1 Nov 2018
  3. Primary completion31 Jan 2026 (estimated)
  4. Study completion31 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04675892
Sponsor's protocol ID
2018-01270
Other IDs
2018
Status last verified
Feb 2024
First submitted
20 Nov 2020
Last updated
20 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing A1 pulley division and A1 pulley division + Resection of one or both slips of the FDS tendon in people with Trigger Finger and Stenosing Tenosynovitis, run by Centre Hospitalier Universitaire Vaudois at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Thierry Christen, MD (+41(0)795561287, thierry.christen@chuv.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in total active finger motion in degrees (time frame: Preoperative (days to weeks prior to surgery), 4 weeks after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in